Table 1 Clinical characteristics of the radical retropubic prostatectomy tissue microarray cohort
From: Nuclear iASPP may facilitate prostate cancer progression
Radical retropubic prostatectomy (n =203) n(%) | |
|---|---|
Median age (range) | 63 (range 44–75) years |
Preoperative PSA | |
≤10 | 79 (38.9) |
10.1–20 | 59 (29.1) |
>20 | 64 (31.5) |
Unknown | 1 |
pT-stage | |
≤pT2 | 94 (46.3) |
≥pT3 | 109 (53.7) |
pN-stage | |
pN0 | 143 (70.4) |
pN1 | 52 (25.6) |
pN2 | 6 (3.0) |
Unknown | 2 |
Gleason grade | |
≤6 | 137 (67.5) |
7 | 36 (17.7) |
≥8 | 29 (14.3) |
Unknown | 1 |
Median FU (range), years | 8.8 (0.1–17.7) |
Developed bone metastases at 10 years | 43 (21.2) |
Prostate cancer-specific death at 10 years | 37 (18.2) |
